We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Top Buys

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$239M
2
HR icon
Healthcare Realty
HR
+$179M
3
HST icon
Host Hotels & Resorts
HST
+$129M
4
EXR icon
Extra Space Storage
EXR
+$126M
5
DOC icon
Healthpeak Properties
DOC
+$93.7M

Top Sells

Rank Stock Value
1
SUI icon
Sun Communities
SUI
+$208M
2
CONE
CyrusOne Inc Common Stock
CONE
+$99.4M
3
AMH icon
American Homes 4 Rent
AMH
+$82.5M
4
OHI icon
Omega Healthcare
OHI
+$76.6M
5
PSA icon
Public Storage
PSA
+$68.1M

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
1051
Regenxbio
RGNX
$622M
$9K ﹤0.01%
208
-24
-10% -$948
ZLAB icon
1052
Zai Lab
ZLAB
$2.1B
$9K ﹤0.01%
210
-12
-5% -$443
DRNA
1053
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$9K ﹤0.01%
386
-50
-11% -$1.01K
AKCA
1054
DELISTED
Akcea Therapeutics Inc
AKCA
$9K ﹤0.01%
530
-63
-11% -$1.17K
FTSV
1055
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$9K ﹤0.01%
239
-30
-11% -$482
DBC icon
1056
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$8K ﹤0.01%
500
– –
FATE icon
1057
Fate Therapeutics
FATE
$283M
$8K ﹤0.01%
410
– –
INVA icon
1058
Innoviva
INVA
$1.57B
$8K ﹤0.01%
572
-73
-11% -$896
VCYT icon
1059
Veracyte
VCYT
$4.44B
$8K ﹤0.01%
276
-21
-7% -$544
ALEC icon
1060
Alector
ALEC
$168M
$7K ﹤0.01%
+389
New +$6.61K
CHRS icon
1061
Coherus Oncology
CHRS
$225M
$7K ﹤0.01%
396
-44
-10% -$811
ENTA icon
1062
Enanta Pharmaceuticals
ENTA
$370M
$7K ﹤0.01%
111
-13
-10% -$806
KPTI icon
1063
Karyopharm Therapeutics
KPTI
$161M
$7K ﹤0.01%
24
-2
-8% -$434
SUPN icon
1064
Supernus Pharmaceuticals
SUPN
$2.73B
$7K ﹤0.01%
296
-36
-11% -$874
TBPH icon
1065
Theravance Biopharma
TBPH
$874M
$7K ﹤0.01%
320
-33
-9% -$641
YMAB
1066
DELISTED
Y-mAbs Therapeutics
YMAB
$7K ﹤0.01%
+224
New +$6.63K
NGM
1067
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$7K ﹤0.01%
+376
New +$5.5K
ATNX
1068
DELISTED
Athenex, Inc. Common Stock
ATNX
$7K ﹤0.01%
22
-3
-12% -$793
GOSS icon
1069
Gossamer Bio
GOSS
$97.5M
$6K ﹤0.01%
+373
New +$7.51K
HCM icon
1070
HUTCHMED
HCM
$1.91B
$6K ﹤0.01%
235
+20
+9% +$438
KBR icon
1071
PUT
KBR
KBR
$4.67B
$6K ﹤0.01%
+500
New +$14.1K
RCKT icon
1072
Rocket Pharmaceuticals
RCKT
$355M
$6K ﹤0.01%
284
-37
-12% -$618
RYTM icon
1073
Rhythm Pharmaceuticals
RYTM
$7.28B
$6K ﹤0.01%
248
+29
+13% +$644
GTHX
1074
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$6K ﹤0.01%
212
-26
-11% -$608
NSTG
1075
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
202
-24
-11% -$583
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.